battlefordsNOW·2 min read·medium

Sask. offers new treatment options to women battling ovarian cancer

P
Pattison Media
Sask. offers new treatment options to women battling ovarian cancer
✦AI Summary

The Saskatchewan government has announced public funding for two new ovarian cancer treatments, Elahere and Keytruda. These therapies aim to provide more options for patients when standard chemotherapy is no longer effective.

Why it matters

This initiative removes financial barriers for patients facing limited treatment options for a difficult-to-detect and often deadly disease.

✦Dive DeeperCreate a free account to unlock

“These two new treatments will provide hope for patients and families facing a difficult cancer diagnosis and ensure access to innovative, high-quality cancer care close to home.”

The Government of Saskatchewan said clinical trials showed that Elahere and Keytruda have helped patients live longer and delayed the progression of the disease. The treatments have both passed national-level safety reviews, and pricing negotiations have been completed through the pan-Canadian Pharmaceutical Alliance, the province added.

About eight to 10 patients across the province are expected to benefit from access to the two new treatments each year.

Ovarian cancer is often deadly and can be difficult to detect at an early stage because symptoms can be hard to recognize, the government noted. While many cases respond to standard treatments, when chemotherapy stops being effective, patients can be left with limited options.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →

Also covering this story

One other newsroom covered this event. We read that version too.

healthpolitics
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in